Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study
暂无分享,去创建一个
E. Ricci | P. Bonfanti | L. Taramasso | A. di Biagio | G. Pellicanò | R. Gulminetti | G. Orofino | B. Celesia | C. Molteni | F. Vichi | G. Madeddu | G. D. De Socio | N. Squillace | B. Menzaghi | E. Sarchi | Antonio Falletta | Eleonora Sarchi